Royalty Pharma shares owned by UBS Group
Historical chart of UBS Group investment in Royalty Pharma
Tip: Access up to 7 years of quarterly data
All positions including Royalty Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Royalty Pharma by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $24M | 867k | 28.09 |
| 2023-09-30 | $20M | 744k | 27.14 |
| 2023-06-30 | $23M | 750k | 30.74 |
| 2023-03-31 | $18M | 502k | 36.03 |
| 2022-12-31 | $29M | 735k | 39.52 |
| 2022-09-30 | $20M | 492k | 39.77 |
| 2022-06-30 | $8.3M | 198k | 42.05 |
| 2022-03-31 | $19M | 478k | 38.92 |
| 2021-12-31 | $18M | 451k | 39.85 |
| 2021-09-30 | $11M | 291k | 36.14 |
| 2021-06-30 | $34M | 820k | 40.99 |
| 2021-03-31 | $19M | 445k | 43.62 |
| 2020-12-31 | $11M | 223k | 50.02 |
| 2020-09-30 | $2.3M | 54k | 42.11 |
| 2020-06-30 | $432k | 8.9k | 48.54 |